Flemming Ørnskov

Flemming Ørnskov (born 1957/58) is a Danish businessman. He has been the chief executive officer (CEO) of Galderma since October 2019.

He was previously the CEO of Shire plc, a FTSE 100 specialty biopharmaceutical company as of 30 April 2013, succeeding Angus Russel. He previously worked for Bayer, Bausch & Lomb and Novartis.

He is also the non-executive chairman of Waters Corporation, a position he's been holding since 2017.

Ørnskov received his MD from the University of Copenhagen, followed by an MBA from INSEAD, and a Master of Public Health (MPH) from Harvard University.

Ørnskov led Galderma's IPO on the Zurich stock exchange on March 22, 2024, one of the biggest offerings in Europe in years and the biggest in Switzerland since 2017. He declares Galderma plans to use the proceeds to pay down debt and invest in its pipeline.

Awards
Top 100 Best-Performing CEOs in the World, 2015 - Harvard Business Review

Top 25 Most Influential People in Biopharma Today, 2013 - Fierce Biotech